2012 Core Therapeutic Module, Infectious Diseases Topics

ACPE Number: 0204-0000-12-954-H01-P
Application-based: 2.0 Credit Hour
Release Date: July 15, 2012
Expiration Date: July 15, 2015

Let ASHP’s new online core therapeutic modules help you prepare for any Board of Pharmacy Specialties (BPS) examination. Get comprehensive, practical guidance for topics in infectious diseases, as well as practice exam questions and references to helpful study resources.  This activity is available July 15, 2012 through July 15, 2015.

In this online CE activity you will determine the most appropriate empiric therapy and monitoring based on patient-specific information and the most current guidelines for the following conditions:

·      Syphilis, gonorrhea, chlamydia, herpes

·      Uncomplicated and complicated urinary tract infections

·      Urinary tract infection in pregnancy

·      Otitis media, sinusitis, pharyngitis

·      Endocarditis

·      Meningitis

·      C. difficile.

 

Led by therapeutic experts, each of the 14 modules (ranging from 1 to 2 hours in length) can be completed consecutively or individually in any order.  The online format offers the convenience of studying at your own pace. 

Included with this online course are complementary study resources including a practice exam and access to a virtual study group for a truly interactive experience. 

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 2 hours (0.2 CEUs) of continuing pharmacy education credit (ACPE activity #0204-0000-12-954-H01-P).

Methods and Format

This activity is one of 14 modules in this series and can be completed consecutively or individually in any order. This online activity consists of audio and slides for one presentation, an attestation statement, and activity evaluation. Participants must view the entire presentation, complete the attestation statement and course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately. The estimated time to complete this activity is 2 hours.

Target Audience

This activity is intended for pharmacy practitioners who are seeking to update their knowledge and skills commensurate with a board certification examination.

Activity Content

The purpose of this activity is to help participants prepare for a Board of Pharmacy Specialty (BPS) examination by providing a review of pertinent topics, practice of required skills and references to helpful study resources. Faculty will discuss therapeutic management of issues and provide resources on the disease state. The activity will assist the participant identify areas needed for in-depth review.

Learning Objectives

After participating in this application-based educational activity, participants should be able to

• Determine the most appropriate empiric therapy and monitoring based on patient-specific information and the most current guidelines for the following conditions:
  • Syphilis, gonorrhea, chlamydia, herpes
  • Uncomplicated and complicated urinary tract infections
  • Urinary tract infection in pregnancy
  • Otitis media, sinusitis, pharyngitis
  • Endocarditis
  • Meningitis
  • C. difficile

Faculty

John Esterly, Pharm.D., BCPS
Assistant Professor of Pharmacy Practice
Chicago State University College of Pharmacy
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois

Dr. John Esterly, Pharm.D., BCPS, is Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy. He also is Infectious Diseases Pharmacist at Northwestern Memorial Hospital in Chicago, Illinois. Dr. Esterly received his Doctor of Pharmacy degree from the University of Illinois Chicago College of Pharmacy. In 2008, he completed a pharmacy practice residency with comprehensive pharmacy services at Mercy Hospital and Medical Center in Chicago, Illinois. Dr. Esterly also complete a 2-year infectious diseases pharmacotherapy fellowship with the Midwestern University Chicago College of Pharmacy in conjunction with Northwestern Memorial Hospital and Rush University Medical Center. In 2009, Dr. Esterly earned board certification as a pharmacotherapy specialist.

Dr. Esterly currently practices as a clinical pharmacist, specializing in the area of infectious diseases and is also an integral member of the antimicrobial stewardship program at Northwestern Memorial Hospital. His research interests include antimicrobial resistance, pharmacokinetics and pharmacodynamics of antimicrobials, and antimicrobial stewardship related outcomes. His work has been presented at several national professional meetings and has been published in peer-reviewed journals. Dr. Esterly is a member of several professional organizations including the Society of Infectious Diseases Pharmacists, the American Society for Microbiology, the American College of Clinical Pharmacy, and the Illinois Council of Health-System Pharmacists. Dr. Esterly also serves as a peer reviewer for both infectious diseases and pharmacy medical journals.

Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.

The faculty and planners report the following relationships:

John Esterly, Pharm.D., BCPS
Dr. Esterly declares that he has no relationships pertinent to this activity.

Douglas Slain, Pharm.D., BCPS
Dr. Slain declares that he has no relationships pertinent to this activity.

Sandra Oh Clarke, B.S.Pharm.
Ms. Oh Clarke declares that she has no relationships pertinent to this activity.

Susan R. Dombrowski, M.S., B.S.Pharm.
Ms. Dombrowski declares that she has no relationships pertinent to this activity.

ASHP staff has no relevant financial relationships to disclose.